TC BioPharm Limited (In Administration)

Hilco is seeking offers to acquire the intellectual property assets of TC BioPharm Limited (a biotechnology company focused on the development of allogeneic gamma delta T-cell therapies for the treatment of cancer and other serious diseases) on behalf of the joint administrators of the company.

The offer deadline is Wednesday 8 April 2026 at 12pm BST.

Further information.